Fluvoxamine for COVID-19: A New Weapon in the Fight?

The antidepressant appears to have some ability to prevent worsening in outpatients with COVID-19

By virtually all metrics, vaccine development for COVID-19 has been an astonishing success. But when it comes to therapeutics, the picture is much more mixed. This means the tip of the spear of the battle against…

Writing about medicine, science, statistics, and the abuses thereof. Commentator at Medscape. Associate Professor of Medicine at Yale University.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

▪️Benefits of Electronic Health Records (EHR):

COVID-19 Pandemic Changes How People Seek Care

COVID 19 Cases, Hospitalizations, and Outbreaks on the Rise in Puerto Rico

Driver Rescue 1122 Jobs 2021 Latest Online Apply

Driver Rescue 1122 Jobs 2021 Latest Online Apply

Flattening 50 Covid-19 Curves

Why don’t we have a COVID-19 vaccine — yet?

Don’t Flatten the Curve. Eradicate the Virus. Once and For All.

Leaving a few things here. (Updated)

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
F. Perry Wilson, MD MSCE

F. Perry Wilson, MD MSCE

Writing about medicine, science, statistics, and the abuses thereof. Commentator at Medscape. Associate Professor of Medicine at Yale University.

More from Medium

We Need to Acknowledge Needles as a Reason for Vaccine Hesitancy

A Truly Unconnected Christmas

Risk and Reward: Vaccine Experts on Boosters, Myocarditis, Omicron, and More

A Guide To Forcing Veganism Down Other People’s Throats